Biocodex, a global leader in microbiota health and pharmaceutical innovation, has partnered with Kinaxis® Inc. (TSX: KXS), a world-renowned provider of end-to-end supply chain orchestration solutions, to modernize and optimize its supply chain processes. This collaboration will enable Biocodex to enhance forecast accuracy, streamline regulatory compliance, and bolster resilience against disruptions.
Biocodex, a French family-owned pharmaceutical company, has evolved from its pioneering roots in microbiota research to become an international leader. Its diverse portfolio focuses on three key areas: microbiota care, women’s health, and orphan diseases. The company serves patients in over 100 countries, supported by three manufacturing facilities located in France and Morocco, along with an R&D center in France.
“We are thrilled to collaborate with Kinaxis and leverage their extensive expertise in the life sciences and pharmaceutical sectors,” said Cécile Jolivet, Chief Procurement and Supply Chain Officer at Biocodex. “Our priority is to deliver medical innovations to patients worldwide. To achieve this, we are investing in building a more resilient and efficient supply chain.”
As Biocodex continues its global expansion, the complexity of its supply chain grows, increasing the need for robust end-to-end orchestration. The Kinaxis Maestro™ platform, tailored specifically for pharmaceutical companies, provides advanced capabilities to address industry-specific challenges, such as managing product expiration, navigating regulatory approvals, and attribute-based planning.
“Patients seeking medical treatments demonstrate resilience every day, and supply chains must mirror that resilience,” said Fabienne Cetre, Executive Vice President, EMEA at Kinaxis. “We are excited to partner with Biocodex to anticipate and manage supply chain disruptions, ensuring patients receive critical medications precisely when they need them.”
With Biocodex joining its growing roster of life sciences customers, Kinaxis continues to strengthen its presence in the pharmaceutical industry. By delivering solutions that address the complexities of supply chain management—from branded and generic medicines to advanced therapies and medical devices—Kinaxis ensures that patients around the world can rely on the availability of life-saving treatments.